Literature DB >> 20161460

An examination of Bayesian statistical approaches to modeling change in cognitive decline in an Alzheimer's disease population.

Al Bartolucci1, Sejong Bae, Karan Singh, H Randall Griffith.   

Abstract

The mini mental state examination (MMSE) is a common tool for measuring cognitive decline in Alzhiemer's Disease (AD) subjects. Subjects are usually observed for a specified period of time or until death to determine the trajectory of the decline which for the most part appears to be linear. However, it may be noted that the decline may not be modeled by a single linear model over a specified period of time. There may be a point called a change point where the rate or gradient of the decline may change depending on the length of time of observation. A Bayesian approach is used to model the trajectory and determine an appropriate posterior estimate of the change point as well as the predicted model of decline before and after the change point. Estimates of the appropriate parameters as well as their posterior credible regions or regions of interest are established. Coherent prior to posterior analysis using mainly non informative priors for the parameters of interest is provided. This approach is applied to an existing AD database.

Entities:  

Year:  2009        PMID: 20161460      PMCID: PMC2791328          DOI: 10.1016/j.matcom.2009.09.002

Source DB:  PubMed          Journal:  Math Comput Simul        ISSN: 0378-4754            Impact factor:   2.463


  15 in total

1.  Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies.

Authors:  C Holmes; N Cairns; P Lantos; A Mann
Journal:  Br J Psychiatry       Date:  1999-01       Impact factor: 9.319

2.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

3.  Predicting time to prostate cancer recurrence based on joint models for non-linear longitudinal biomarkers and event time outcomes.

Authors:  Donna K Pauler; Dianne M Finkelstein
Journal:  Stat Med       Date:  2002-12-30       Impact factor: 2.373

4.  Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation.

Authors:  C Holmes; C Ballard; D Lehmann; A David Smith; H Beaumont; I N Day; M Nadeem Khan; S Lovestone; M McCulley; C M Morris; D G Munoz; K O'Brien; C Russ; T Del Ser; D Warden
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

5.  Determination of the hyperparameters of a prior probability model in survival analysis.

Authors:  R Birch; A A Bartolucci
Journal:  Comput Programs Biomed       Date:  1983 Aug-Oct

6.  A Bayesian change-point problem with an application to the prediction and detection of ovulation in women.

Authors:  R L Carter; B J Blight
Journal:  Biometrics       Date:  1981-12       Impact factor: 2.571

7.  Test-retest reliable coefficients and 5-year change scores for the MMSE and 3MS.

Authors:  Tom N Tombaugh
Journal:  Arch Clin Neuropsychol       Date:  2005-06       Impact factor: 2.813

8.  Rate of cognitive decline in Alzheimer's disease is associated with EEG alpha power.

Authors:  M A Kuskowski; J A Mortimer; G K Morley; S M Malone; A J Okaya
Journal:  Biol Psychiatry       Date:  1993 Apr 15-May 1       Impact factor: 13.382

9.  Population-based norms for the Mini-Mental State Examination by age and educational level.

Authors:  R M Crum; J C Anthony; S S Bassett; M F Folstein
Journal:  JAMA       Date:  1993-05-12       Impact factor: 56.272

10.  Association of interleukin-6 and other biologic variables with depression in older people living in the community.

Authors:  A N Dentino; C F Pieper; M K Rao; M S Currie; T Harris; D G Blazer; H J Cohen
Journal:  J Am Geriatr Soc       Date:  1999-01       Impact factor: 5.562

View more
  3 in total

1.  Bayesian graphical network analyses reveal complex biological interactions specific to Alzheimer's disease.

Authors:  Alan Rembach; Francesco C Stingo; Christine Peterson; Marina Vannucci; Kim-Anh Do; William J Wilson; S Lance Macaulay; Timothy M Ryan; Ralph N Martins; David Ames; Colin L Masters; James D Doecke
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  Change point models for cognitive tests using semi-parametric maximum likelihood.

Authors:  Ardo van den Hout; Graciela Muniz-Terrera; Fiona E Matthews
Journal:  Comput Stat Data Anal       Date:  2013-01       Impact factor: 1.681

3.  Sample size and classification error for Bayesian change-point models with unlabelled sub-groups and incomplete follow-up.

Authors:  Simon R White; Graciela Muniz-Terrera; Fiona E Matthews
Journal:  Stat Methods Med Res       Date:  2016-08-08       Impact factor: 3.021

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.